Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins.
Skip Nav Destination
Article navigation
4 March 2002
Brief Definitive Report|
March 04 2002
Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
L. Willemijn Vader,
L. Willemijn Vader
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Arnoud de Ru,
Arnoud de Ru
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Yvonne van der Wal,
Yvonne van der Wal
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Yvonne M.C. Kooy,
Yvonne M.C. Kooy
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Willemien Benckhuijsen,
Willemien Benckhuijsen
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
M. Luisa Mearin,
M. Luisa Mearin
2Department of Paediatrics, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Jan Wouter Drijfhout,
Jan Wouter Drijfhout
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Peter van Veelen,
Peter van Veelen
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
Frits Koning
Frits Koning
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Search for other works by this author on:
L. Willemijn Vader
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Arnoud de Ru
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Yvonne van der Wal
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Yvonne M.C. Kooy
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Willemien Benckhuijsen
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
M. Luisa Mearin
2Department of Paediatrics, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Jan Wouter Drijfhout
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Peter van Veelen
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Frits Koning
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2300 RC Leiden, Netherlands
Address correspondence to F. Koning, Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands. Phone: 31-0-71-526-6673; Fax: 31-0-71-521-6751; E-mail: [email protected]
Received:
December 06 2001
Accepted:
January 14 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (5): 643–649.
Article history
Received:
December 06 2001
Accepted:
January 14 2002
Citation
L. Willemijn Vader, Arnoud de Ru, Yvonne van der Wal, Yvonne M.C. Kooy, Willemien Benckhuijsen, M. Luisa Mearin, Jan Wouter Drijfhout, Peter van Veelen, Frits Koning; Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease . J Exp Med 4 March 2002; 195 (5): 643–649. doi: https://doi.org/10.1084/jem.20012028
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement